2025 Silent Capital Report now available. Where family offices and LPs are actually deploying. [Download for free →]
About usSign in
Status
ACTIVE
Global HQ
Las Vegas, United States
Countries of investment
  • United States
Investment stages
  • Pre-Seed
  • Seed
  • Series A
Industries
  • AI
  • Deep Tech
  • Health Tech
  • Fintech
  • Cybersecurity
  • Robotics
About
Cannage Capital is a Las Vegas-based venture capital firm focused on artificial intelligence. Their focus spans semiconductors, software infrastructure, healthtech, fintech and robotics across the United States. The firm supports founders from pre-seed through Series A stages.
Min check size
$100K
Max check size
$1.5M
Fund size
NPS

Investment Thesis

Cannage Capital is a pre-seed to Series A stage firm investing across the AI stack, from semiconductors and software infrastructure to applications in industries such as health, finance and security. The firm differentiates itself through an interdisciplinary approach and a team that previously backed Cruise, Covariant, Hinge Health and Sardine.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Founded in 2024 in Las Vegas by Shelley Zhuang, who holds a PhD in Computer Science from UC Berkeley, with partner Jake Smith. Zhuang previously founded 11.2 Capital, whose $49M debut fund made a seed investment in Hinge Health that became a stake worth roughly $200M at IPO. The team has previously backed Cruise, Covariant, Sardine, Forter and Ginkgo Bioworks.

Team

Shelley Zhuang - Founder & Managing Partner

Jake Smith - Partner

Tien Tran - CFO

Portfolio

Airrived

Noetik

Deep Genomics

Ginkgo Bioworks

Cruise

Hinge Health

Covariant

Sardine

Forter

HUMAN

Fund number
Year Founded
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp